Log In Sign up
The largest database of trusted experimental protocols

Contour next glucose monitor

Manufactured by Bayer
Visit Supplier

The Bayer Contour Next glucose monitor is a device designed to measure blood glucose levels. It provides users with a digital readout of their current glucose level.

Automatically generated - may contain errors

Lab products found in correlation

Male sprague dawley rat, by Charles River Laboratories (4 mentions) Streptozotocin (stz), by MedChemExpress (1 mentions)

Close spelling variants of this product

Contour Next (80 citations) Contour glucose monitor (7 citations)

6 protocols using contour next glucose monitor

1

Streptozotocin-Induced Diabetes in Rats

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
Male Sprague Dawley rats (Charles River) were used for experiments. Animal studies were performed in accordance with the guidelines for the care and use of laboratory animals; all protocols were approved by the Stanford Institutional Animal Care and Use Committee (Protocol #32873). The protocol used for diabetes induction using streptozotocin (STZ) was adapted from the protocol by Kenneth K. Wu and Youming Huan and was performed as previously reported.21 –22 (link), 26 –27 Briefly, Male Sprague Dawley rats 160–230 g (8–10 weeks) were weighed and fasted in the morning 6–8 hours prior to treatment with STZ (MedChemExpress). STZ was protected from light and diluted to 10 mg/mL in the sodium citrate buffer immediately before injection. STZ solution was injected intraperitoneally at 65mg/kg into each rat. Rats were provided with water containing 10% sucrose for 24 hours after injection with STZ and were given subcutaneous saline injections daily to prevent dehydration. Rat blood glucose levels were tested for hyperglycemia daily after the STZ treatment via tail vein blood collection using a handheld Bayer Contour Next glucose monitor (Bayer). Diabetes was defined as having three consecutive blood glucose measurements >400 mg/dL in non-fasted rats.
Maikawa C.L., d’Aquino A.I., Vuong E.T., Su B., Zou L., Chen P.C., Nguyen L.T., Autzen A.A., Mann J.L., Webber M.J, & Appel E.A. (2021). Affinity-Directed Dynamics of Host–Guest Motifs for Pharmacokinetic Modulation via Supramolecular PEGylation. Biomacromolecules, 22(8), 3565-3573.
+ Open protocol
+ Expand
2

Streptozotocin-Induced Diabetes in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male Sprague Dawley rats (Charles River) were used for experiments. Animal studies were performed in accordance with the guidelines for the care and use of laboratory animals; all protocols were approved by the Stanford Institutional Animal Care and Use Committee. The protocol used for STZ induction adapted from the protocol by Kenneth K. Wu and Youming Huan.[51 ] Briefly, Male Sprague Dawley rats 160-230g (8-10 weeks) were weighed and fasted 6-8 hours prior to treatment with STZ. STZ was diluted to 10mg/mL in the sodium citrate buffer immediately before injection. STZ solution was injected intraperitoneally at 65mg/kg into each rat. Rats were provided with water containing 10% sucrose for 24 hours after injection with STZ. Rat blood glucose levels were tested for hyperglycemia daily after the STZ treatment via tail vein blood collection using a handheld Bayer Contour Next glucose monitor (Bayer). Diabetes was defined as having 3 consecutive blood glucose measurements >400 mg/dL in non-fasted rats.
Maikawa C.L., Smith A.A., Zou L., Roth G.A., Gale E.C., Stapleton L.M., Baker S.W., Mann J.L., Yu A.C., Correa S., Grosskopf A.K., Liong C.S., Meis C.M., Chan D., Troxell M., Maahs D.M., Buckingham B.A., Webber M.J, & Appel E.A. (2020). A co-formulation of supramolecularly stabilized insulin and pramlintide enhances meal-time glucagon suppression in diabetic pigs. Nature biomedical engineering, 4(5), 507-517.
+ Open protocol
+ Expand
3

Streptozotocin Induced Diabetes in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male Sprague Dawley rats (Charles River) were used for experiments. Animal studies were performed in accordance with the guidelines for the care and use of laboratory animals; all protocols were approved by the Stanford Institutional Animal Care and Use Committee (Protocol #32 873). The protocol used for streptozotocin (STZ) induction was adapted from the protocol by Kenneth K. Wu and Youming Huan and has been previously reported.[8, 12, 13, 21] Briefly, Male Sprague Dawley rats 160–230 g (8–10 weeks) were weighed and fasted in the morning 6–8 h prior to treatment with STZ. STZ was diluted to 10 mg mL−1 in the sodium citrate buffer immediately before injection. STZ solution was injected intraperitoneally at 65 mg kg−1 into each rat. Rats were provided with water containing 10% sucrose for 24 h after injection with STZ. Rat blood glucose levels were tested for hyperglycemia daily after the STZ treatment via tail vein blood collection using a handheld Bayer Contour Next glucose monitor (Bayer). Diabetes was defined as having three consecutive blood glucose measurements >400 mg dL−1 in non‐fasted rats.
Maikawa C.L., Chen P.C., Vuong E.T., Nguyen L.T., Mann J.L., d'Aquino A.I., Lal R.A., Maahs D.M., Buckingham B.A, & Appel E.A. (2021). Ultra‐Fast Insulin–Pramlintide Co‐Formulation for Improved Glucose Management in Diabetic Rats. Advanced Science, 8(21), 2101575.
+ Open protocol
+ Expand
4

Streptozotocin-Induced Diabetes in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male Sprague Dawley rats (Charles River) were used for experiments. Animal studies were performed in accordance with the guidelines for the care and use of laboratory animals; all protocols were approved by the Stanford Institutional Animal Care and Use Committee. The protocol used for STZ induction adapted from the protocol by Kenneth K. Wu and Youming Huan.[51 ] Briefly, Male Sprague Dawley rats 160-230g (8-10 weeks) were weighed and fasted 6-8 hours prior to treatment with STZ. STZ was diluted to 10mg/mL in the sodium citrate buffer immediately before injection. STZ solution was injected intraperitoneally at 65mg/kg into each rat. Rats were provided with water containing 10% sucrose for 24 hours after injection with STZ. Rat blood glucose levels were tested for hyperglycemia daily after the STZ treatment via tail vein blood collection using a handheld Bayer Contour Next glucose monitor (Bayer). Diabetes was defined as having 3 consecutive blood glucose measurements >400 mg/dL in non-fasted rats.
Maikawa C.L., Smith A.A., Zou L., Roth G.A., Gale E.C., Stapleton L.M., Baker S.W., Mann J.L., Yu A.C., Correa S., Grosskopf A.K., Liong C.S., Meis C.M., Chan D., Troxell M., Maahs D.M., Buckingham B.A., Webber M.J, & Appel E.A. (2020). A co-formulation of supramolecularly stabilized insulin and pramlintide enhances meal-time glucagon suppression in diabetic pigs. Nature biomedical engineering, 4(5), 507-517.
+ Open protocol
+ Expand
5

Streptozotocin-Induced Diabetes in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal studies were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals and the Animal Welfare Act Regulations; all protocols were approved by the Stanford Institutional Animal Care and Use Committee. The protocol used for STZ induction was adapted from the protocol by Kenneth K. Wu and Youming Huan40 . Briefly, male Sprague Dawley rats (Charles River Laboratory) of 200–300g (8–10 weeks) were weighed and fasted in the morning prior to treatment in the afternoon with STZ (6–8 hours). STZ was kept protected from light; immediately before administration, individual doses were diluted to 10 mg/mL in sodium citrate buffer. STZ solution was vortexed and administered intra-peritoneally to each rat at a dose of 65 mg/kg. Water containing 10% sucrose was given to rats for 24 hours after injection with STZ to prevent hypoglycemia. Rat blood glucose levels were tested for hyperglycemia daily after the STZ treatment via tail vein blood collection using a handheld Bayer Contour Next glucose monitor. Diabetes was defined as three consecutive blood glucose measurements >400 mg/dL in non-fasted rats.
Poudineh M., Maikawa C.L., Ma E.Y., Pan J., Mamerow D., Hang Y., Baker S.W., Beirami A., Yoshikawa A., Eisenstein M., Kim S., Vučković J., Appel E.A, & Soh H.T. (2020). A fluorescence sandwich immunoassay for the real-time continuous detection of glucose and insulin in live animals. Nature biomedical engineering, 5(1), 53-63.
+ Open protocol
+ Expand
6

Streptozotocin-Induced Diabetes in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal studies were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals and the Animal Welfare Act Regulations; all protocols were approved by the Stanford Institutional Animal Care and Use Committee. The protocol used for STZ induction was adapted from the protocol by Kenneth K. Wu and Youming Huan40 . Briefly, male Sprague Dawley rats (Charles River Laboratory) of 200–300g (8–10 weeks) were weighed and fasted in the morning prior to treatment in the afternoon with STZ (6–8 hours). STZ was kept protected from light; immediately before administration, individual doses were diluted to 10 mg/mL in sodium citrate buffer. STZ solution was vortexed and administered intra-peritoneally to each rat at a dose of 65 mg/kg. Water containing 10% sucrose was given to rats for 24 hours after injection with STZ to prevent hypoglycemia. Rat blood glucose levels were tested for hyperglycemia daily after the STZ treatment via tail vein blood collection using a handheld Bayer Contour Next glucose monitor. Diabetes was defined as three consecutive blood glucose measurements >400 mg/dL in non-fasted rats.
Poudineh M., Maikawa C.L., Ma E.Y., Pan J., Mamerow D., Hang Y., Baker S.W., Beirami A., Yoshikawa A., Eisenstein M., Kim S., Vučković J., Appel E.A, & Soh H.T. (2020). A fluorescence sandwich immunoassay for the real-time continuous detection of glucose and insulin in live animals. Nature biomedical engineering, 5(1), 53-63.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!